TDOC icon

Teladoc Health

7.76 USD
-0.20
2.51%
At close Apr 1, 3:59 PM EDT
After hours
7.80
+0.04
0.52%
1 day
-2.51%
5 days
-10.60%
1 month
-17.71%
3 months
-18.49%
6 months
-12.42%
Year to date
-18.49%
1 year
-47.74%
5 years
-95.23%
10 years
-72.77%
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

44% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 54

13% more call options, than puts

Call options by funds: $65.6M | Put options by funds: $58.3M

11% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 100

5% more funds holding

Funds holding: 358 [Q3] → 375 (+17) [Q4]

0% more capital invested

Capital invested by funds: $1.16B [Q3] → $1.16B (+$354K) [Q4]

0.09% less ownership

Funds ownership: 73.89% [Q3] → 73.8% (-0.09%) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$12
55%
upside
Avg. target
$12.50
61%
upside
High target
$13.50
74%
upside

5 analyst ratings

positive
80%
neutral
20%
negative
0%
Goldman Sachs
David Roman
30% 1-year accuracy
6 / 20 met price target
68%upside
$13
Buy
Maintained
3 Mar 2025
Piper Sandler
Jessica Tassan
38% 1-year accuracy
9 / 24 met price target
55%upside
$12
Overweight
Maintained
27 Feb 2025
B of A Securities
Allen Lutz
73% 1-year accuracy
11 / 15 met price target
74%upside
$13.50
Neutral
Maintained
12 Feb 2025
RBC Capital
Sean Dodge
31% 1-year accuracy
11 / 35 met price target
55%upside
$12
Outperform
Maintained
24 Jan 2025
Oppenheimer
Michael Wiederhorn
17% 1-year accuracy
5 / 29 met price target
55%upside
$12
Outperform
Maintained
24 Jan 2025

Financial journalist opinion

Based on 28 articles about TDOC published over the past 30 days

Positive
The Motley Fool
2 days ago
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?
Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies.
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?
Negative
Zacks Investment Research
4 days ago
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?
Negative
Zacks Investment Research
5 days ago
Teladoc (TDOC) Flat As Market Sinks: What You Should Know
Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close.
Teladoc (TDOC) Flat As Market Sinks: What You Should Know
Neutral
Zacks Investment Research
1 week ago
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day.
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
Neutral
Accesswire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Neutral
PRNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Neutral
The Motley Fool
2 weeks ago
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?
Telemedicine specialist Teladoc Health (TDOC 1.53%) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth slowed down considerably while it remained unprofitable.
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?
Neutral
Accesswire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Positive
Zacks Investment Research
2 weeks ago
Teladoc Expands Specialty Care Access With Carrum Health Partnership
TDOC partners with Carrum Health in a bid to expand access to specialty care.
Teladoc Expands Specialty Care Access With Carrum Health Partnership
Neutral
Accesswire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
Charts implemented using Lightweight Charts™